Whole-exome sequencing reveals novel candidate single nucleotide variations for preventing adverse effects of levonorgestrel implantation

References

• 1. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud. Fam. Plan. 45(3), 301–314 (2014).
  MedlineGoogle Scholar
• 2. Bearak J, Popinchalk A, Alkema L, Sedgh G. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob. Health 6(4), e380–e389 (2018).
  MedlineGoogle Scholar
• 3. Tsegaye AT, Mengistu M, Shimeka A. Prevalence of unintended pregnancy and associated factors among married women in west Belessa Woreda, Northwest Ethiopia, 2016. Reprod. Health 15(1), 201 (2018).
  MedlineGoogle Scholar
• 4. Niemeyer Hultstrand J, Omer Abuelgasim K, Tydén T, Jonsson M, Maseko N, Målqvist M. The perpetuating cycle of unplanned pregnancy: underlying causes and implications in Eswatini. Cult. Health Sexuality 1–16 (2020).
  Google Scholar
• 5. Bearak J, Popinchalk A, Ganatra B et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob. Health 8(9), e1152–e1161 (2020).
  MedlineGoogle Scholar
• 6. Belay D, Alem A, Zerihun S et al. Unintended pregnancy and associated factors among unmarried female students: A case of Bahir Dar University. Heliyon 6(6), e04309 (2020).
  MedlineGoogle Scholar
• 7. Vrettakos C, Bajaj T. Levonorgestrel. In: StatPearls. Edition. StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC, FL, USA (2020).
  Google Scholar
• 8. Kahlenborn C, Peck R, Severs WB. Mechanism of action of levonorgestrel emergency contraception. Linacre Q. 82(1), 18–33 (2015).
  MedlineGoogle Scholar
• 9. Matsuo M, Hirota Y, Fukui Y et al. Levonorgestrel inhibits embryo attachment by eliminating uterine induction of leukemia inhibitory factor. Endocrinology 161(2), (2020).
  Google Scholar
• 10. Levonorgestrel implant. In: Drugs and Lactation Database (LactMed) (Edition). National Library of Medicine (US), MD, USA (2006).
  Google Scholar
• 11. Shoupe D, Mishell DR. Norplant: subdermal implant system for long-term contraception. Am. J. Obstet. Gynecol. 160(5 Pt 2), 1286–1292 (1989).
  Medline CASGoogle Scholar
• 12. Peralta O, Diaz S, Croxatto H. Subdermal contraceptive implants. J. Steroid Biochem. Mol. Biol. 53(1–6), 223–226 (1995).
  Medline CASGoogle Scholar
• 13. Sivin I. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Saf. 26(5), 303–335 (2003).
  Medline CASGoogle Scholar
• 14. Mainwaring R, Hales HA, Stevenson K et al. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. Contraception 51(3), 149–153 (1995).
  Medline CASGoogle Scholar
• 15. Ulintz PJ, Wu W, Gates CM. Bioinformatics analysis of whole exome sequencing data. Methods Mol. Biol. 1881, 277–318 (2019).
  Medline CASGoogle Scholar
• 16. Udagawa C, Nakamura H, Ohnishi H et al. Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity. Cancer Sci. 109(2), 446–452 (2018).
  Medline CASGoogle Scholar
• 17. Gréen H, Hasmats J, Kupershmidt I et al. Using whole-exome sequencing to identify genetic markers for carboplatin and gemcitabine-induced toxicities. Clin. Cancer Res. 22(2), 366–373 (2016).
  Medline CASGoogle Scholar
• 18. Lazorwitz A, Dindinger E, Harrison M, Aquilante CL, Sheeder J, Teal S. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users. Contraception 102(3), 180–185 (2020).
  Medline CASGoogle Scholar
• 19. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4(1), 44–57 (2009).
  Medline CASGoogle Scholar
• 20. Shen J, Li Z, Chen J, Song Z, Zhou Z, Shi Y. SHEsisPlus, a toolset for genetic studies on polyploid species. Sci. Rep. 6, 24095 (2016).
  Medline CASGoogle Scholar
• 21. Wilkins MR, Gasteiger E, Bairoch A et al. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol. 112, 531–552 (1999).
  Medline CASGoogle Scholar
• 22. Letunic I, Doerks T, Bork P. SMART: recent updates, new developments and status in 2015. Nucleic Acids Res. 43(Database issue), D257–260 (2015).
  Medline CASGoogle Scholar
• 23. Hofmann BM, Apter D, Bitzer J et al. Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route. Eur. J. Contracept. Reprod. Health Care 25(6), 417–426 (2020).
  MedlineGoogle Scholar
• 24. Shen AR, Zhong X, Tang TT et al. Integrin, exosome and kidney disease. Front. Physiol. 11, 627800 (2020).
  MedlineGoogle Scholar
• 25. Kawamura E, Hamilton GB, Miskiewicz EI, MacPhee DJ. Examination of FERMT1 expression in placental chorionic villi and its role in HTR8-SVneo cell invasion. Histochem. Cell Biol. 155(6), 669–681 (2021).
  Medline CASGoogle Scholar
• 26. Quenby S, Anim-Somuah M, Kalumbi C, Farquharson R, Aplin JD. Different types of recurrent miscarriage are associated with varying patterns of adhesion molecule expression in endometrium. Reprod. Biomed. Online 14(2), 224–234 (2007).
  Medline CASGoogle Scholar
• 27. Singh H, Aplin JD. Adhesion molecules in endometrial epithelium: tissue integrity and embryo implantation. J. Anat. 215(1), 3–13 (2009).
  Medline CASGoogle Scholar
• 28. Brakebusch C, Hirsch E, Potocnik A, Fässler R. Genetic analysis of beta1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J. Cell Sci. 110(Pt 23), 2895–2904 (1997).
  Medline CASGoogle Scholar
• 29. Somerville RP, Jungers KA, Apte SS. Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation. J. Biol. Chem. 279(49), 51208–51217 (2004).
  Medline CASGoogle Scholar
• 30. Cain SA, Mularczyk EJ, Singh M, Massam-Wu T, Kielty CM. ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. Sci. Rep. 6, 35956 (2016).
  Medline CASGoogle Scholar
• 31. Kutz WE, Wang LW, Bader HL et al. ADAMTS10 protein interacts with fibrillin-1 and promotes its deposition in extracellular matrix of cultured fibroblasts. J. Biol. Chem. 286(19), 17156–17167 (2011).
  Medline CASGoogle Scholar
• 32. Coricovac D, Farcas C, Nica C et al. Ethinylestradiol and levonorgestrel as active agents in normal skin, and pathological conditions induced by UVB exposure: in vitro and in ovo assessments. Int. J. Mol. Sci. 19(11), 3600 (2018).
  Google Scholar
• 33. Stewart CJ, Leake R. Endometrial synovial-like metaplasia associated with levonorgestrel-releasing intrauterine system. Int. J. Gynecol. Pathol. 34(6), 570–575 (2015).
  Medline CASGoogle Scholar
• 34. Kutz WE, Wang LW, Dagoneau N et al. Functional analysis of an ADAMTS10 signal peptide mutation in Weill-Marchesani syndrome demonstrates a long-range effect on secretion of the full-length enzyme. Hum. Mutat. 29(12), 1425–1434 (2008).
  Medline CASGoogle Scholar
• 35. Dagoneau N, Benoist-Lasselin C, Huber C et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am. J. Hum. Genet. 75(5), 801–806 (2004).
  Medline CASGoogle Scholar
• 36. Martin RD. The evolution of human reproduction: a primatological perspective. Am. J. Phys. Anthropol. (Suppl. 45), 59–84 (2007).
  MedlineGoogle Scholar
• 37. Noyes RW, Hertig AT, Rock J. Reprint of: dating the endometrial biopsy. Fertil. Steril. 112(1 Suppl. 4), e93–e115 (2019).
  Medline CASGoogle Scholar
• 38. Zhao X, Tang X, Ma T et al. Levonorgestrel inhibits human endometrial cell proliferation through the upregulation of gap junctional intercellular communication via the nuclear translocation of Ser255 Phosphorylated Cx43. BioMed Res Int. 2015, 758684 (2015).
  MedlineGoogle Scholar
• 39. Chai M, Su S, Dong B. Morphological and ultrastructural changes in human endometrium following low-dose levonorgestrel contraceptive intrauterine systems (LNG-IUS-12) 13.5 mg. J. Obstet. Gynaecol. India 65(5), 323–327 (2015).
  Medline CASGoogle Scholar
• 40. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2(1), a001008 (2010).
  MedlineGoogle Scholar
• 41. Marini MG, Perrini C, Esposti P et al. Effects of platelet-rich plasma in a model of bovine endometrial inflammation in vitro. Reprod. Biol. Endocrinol. 14(1), 58 (2016).
  MedlineGoogle Scholar
• 42. Dahabreh IJ, Schmid CH, Lau J, Varvarigou V, Murray S, Trikalinos TA. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. Am. J. Epidemiol. 177(12), 1317–1325 (2013).
  MedlineGoogle Scholar
• 43. Gallegos-Arreola MP, Figuera-Villanueva LE, Puebla-Pérez AM, Montoya-Fuentes H, Suarez-Rincon AE, Zúñiga-González GM. Association of TP53 gene codon 72 polymorphism with endometriosis in Mexican women. Genet. Mol. Res. 11(2), 1401–1408 (2012).
  Medline CASGoogle Scholar
• 44. Zhang Y, Cai Q, Shu XO et al. Whole-exome sequencing identifies novel somatic mutations in Chinese breast cancer patients. J.Mol. Genet. Med. 9(4), 183 (2015).
  MedlineGoogle Scholar
• 45. Jiang Y, Wu R, Chen C, You ZF, Luo X, Wang XP. Six novel rare non-synonymous mutations for migraine without aura identified by exome sequencing. J. Neurogenet. 29(4), 188–194 (2015).
  Medline CASGoogle Scholar
• 46. Bamshad MJ, Ng SB, Bigham AW et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12(11), 745–755 (2011).
  Medline CASGoogle Scholar